Cinalukast is a potent, selective CysLT1 (LTD4) leukotriene receptor antagonist. It is used in the treatment of asthma, cinalukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor, CysLT1, in the human airway. Cinalukast inhibits the actions of LTD4 at the CysLT1 receptor, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus. References: Durán Merás I, Espinosa-Mansilla A, Rodríguez DA. Complexation study of cinalukast and montelukast with cyclodextrines. J Pharm Biomed Anal. 2007 Feb 19;43(3):1025-32. Epub 2006 Nov 21. PubMed PMID: 17118608.

纯度：≥98%

CAS：128312-51-6